Vai al contenuto principale
Ofev (Nintedanib) 150 mg – Treatment for Pulmonary Fibrosis  Ofev (Nintedanib) - Macrocare Health Blog

Ofev (Nintedanib) 150 mg – Treatment for Pulmonary Fibrosis Ofev (Nintedanib)

Ofev (Nintedanib) is a targeted therapy used in the treatment of certain chronic lung diseases, especially Idiopathic Pulmonary Fibrosis (IPF). It helps slow lung function decline and reduce disease progression.

 

What is Ofev (Nintedanib)?

Ofev belongs to a class of drugs known as Tyrosine Kinase Inhibitors (TKIs). It works by blocking signals involved in the formation of fibrotic tissue inside the lungs.

In pulmonary fibrosis, scar tissue gradually forms in the lungs, affecting breathing and lung function. Ofev helps to:

  • Slow down fibrotic tissue formation
  • Reduce the rate of lung function decline
  • Improve disease control

In simple terms:
It helps slow the progression of lung scarring.

 

Indications

Ofev (Nintedanib) is used in:

  • Idiopathic Pulmonary Fibrosis (IPF)
  • Certain chronic fibrotic lung diseases
  • Pulmonary fibrosis associated with autoimmune diseases
 

Dosage and Administration

  • Standard dose: 150 mg twice daily
  • Taken orally
  • Preferably taken with food
  • Should be taken consistently every day
  • Dose adjustments may be required based on patient tolerance
 

Common Side Effects

May include:

  • Diarrhea
  • Nausea or vomiting
  • Loss of appetite
  • Abdominal pain
  • Elevated liver enzymes
  • Weight loss

Regular medical monitoring is important during treatment.

 

Monitoring During Treatment

Patients on Ofev (Nintedanib) require:

  • Liver function tests
  • Monitoring of gastrointestinal symptoms
  • Lung function assessment
  • Evaluation of treatment response
 

Availability & How to Access Treatment

Ofev (Nintedanib) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

 

Ofev (Nintedanib) Ofev (Nintedanib) 150 mg is an effective therapy that helps slow the progression of pulmonary fibrosis and improve disease control, especially in IPF and chronic fibrotic lung diseases.


Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

 
 

Inserisci il numero di cellulare

Condividi il tuo numero di telefono così possiamo contattarti per conoscere il tuo disturbo di salute.

Privacy protetta: le tue informazioni mediche e personali sono mantenute completamente riservate e protette con standard di sicurezza di livello industriale.

CONTATTACI

Contattaci

Condividi il tuo numero di telefono così possiamo contattarti per conoscere il tuo disturbo di salute.

Linea diretta

+20 106 604 2282

Chiama

Indirizzo email

[email protected]

Scrivi